Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment
Clinical trial NCT00416351 · COMPLETED
Trial details
- NCT number
- NCT00416351
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-27
- Primary completion
- 2021-03-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.